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Abstract  
Ageing and age-related diseases share some basic pillars that largely converge on inflammation. 
During ageing chronic, sterile, low-grade inflammation — called inflammaging — develops, which 
contributes to the pathogenesis of age-related diseases. From an evolutionary perspective, a variety 
of stimuli sustain inflammaging, including pathogens (non-self), endogenous cell debris and 
misplaced molecules (self) and nutrients and gut microbiota (quasi-self). A limited number of 
receptors, whose degeneracy allows them to recognize many signals and to activate the innate 
immune responses, sense these stimuli. In this situation, metaflammation (the metabolic 
inflammation accompanying metabolic diseases) is thought to be the form of chronic inflammation 
that is driven by nutrient excess or overnutrition; metaflammation is characterised by the same 
mechanisms underpinning inflammaging. The gut microbiota has a central role  in both 
metaflammation and in inflammaging due to its ability to release inflammatory products, to 
contribute to circadian rhythms and to crosstalk with other organs. We argue that chronic diseases 
are not only the result of ageing and inflammaging, but they also accelerate the ageing process and 
can be considered a manifestation of accelerated ageing. Finally, we propose the use of new 
biomarkers (DNA methylation, glycomics, metabolomics and lipidomics) that are capable of 
assessing biological versus chronological age in metabolic diseases.  
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[H1] Introduction  
 
The new geroscience field [G] offers a new perspective to address the increasing incidence of 
chronic age-related diseases, including metabolic disorders such as the metabolic syndrome, 
obesity, type 2 diabetes mellitus (T2DM) and cardiovascular diseases. The increasing incidence of 
these pathologies is a reflection of the increasing ageing population observed worldwide . The basic 
assumption of geroscience is that the mechanisms driving ageing and age-related diseases largely 
overlap, with seven common ‘pillars’ (mechanisms of ageing and major area of research) having 
been identified (FIG. 1)1. The great novelty is that experimental data emerged suggesting that these 
pillars are relatively few (adaptation to stress, epigenetics, inflammation, macromolecular damage, 
metabolism, proteostasis, stem cells and regeneration). Even more importantly, these pillars do not 
operate separately but are interconnected, influencing and modulating each other, thus constituting 
an integrated network 1,2. Accordingly, the new geroscience approach proposes to counteract all 
major age-related diseases together, and not individually, by focusing on the basic ageing 
mechanisms underlying these diseases. This new approach should change the conventional views 
that often separate ageing and age-related diseases. Indeed, despite ageing being a major risk factor 
for age-related diseases, researchers often neglect the ageing process when they are investigating 
the mechanisms underpinning these diseases. Conversely, the contribution of age-related diseases in 
accelerating ageing is also underestimated.  
 
Interestingly, the tightly networked ageing pillars converge on inflammation as impairment of any 
one pillar fuels inflammation, which subsequently affects all the other pillars. This chronic, sterile 
(occurring in the absence of infection and primarily driven by endogenous signals), low-grade 
inflammation that occurs during ageing is called inflammaging. A major characteristic of 
inflammaging is the chronic activation of the innate immune system3 where macrophage plays a 
central role. Ilya Metchnikoff was the first to describe the macrophage in invertebrates and to define 
its pivotal role in the ingestion of foreign material (a primitive type of nutrition) and subsequent 
mounting of ‘physiological’ inflammation, which is a basic mechanism to cope with and neutralize 
a large variety of stressors 4. Several cellular and molecular mechanisms are involved in 
inflammaging, including cellular senescence, mitochondrial dysfunction, defective autophagy and 
mitophagy, activation of the inflammasome [G], dysregulation of ubiquitin-proteasome system, 
activation of the DNA damage response and dysbiosis (changes in the composition of the host 
microbiota) 5.		
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This Review will focus on the similarities and differences between inflammaging and 
metaflammation6 (the metabolic inflammation driven by nutrient excess or overnutrition that is 
present in metabolic diseases such as obesity and T2DM). This comparative immune–metabolic 
analysis presents a new perspective on the relationship between basic cellular and molecular 
mechanisms underpinning the ageing process and the chronic age-related metabolic diseases. 
Moreover, this Review will discuss the possible use of new biomarkers, which have been developed 
within the framework of geroscience, capable of distinguishing between biological and 
chronological age in metabolic diseases.  
 
[H1] Immune–metabolic inflammaging 
 
[H2]  Evolutionary insight 
The most challenging events for an organism’s survival are nutrient deprivation and infection by 
pathogens; therefore, competition for food and the response to infectious diseases are the main 
factors that determine the ecological dynamics of populations and species and influence evolution 7–
9.. Accordingly, food sources, metabolism, endocrine responses, innate immune responses and 
inflammation co-evolved, and the macrophage is a master cell at the interface between metabolism 
and immunity 10. Several lines of evidence suggest that the immune, metabolic and endocrine 
responses co-evolved. Firstly, macrophages and adipocytes demonstrate remarkable functional 
overlap, as both cell types secrete cytokines and can be activated by bacterial products, such as 
lipopolysaccharide;11  furthermore, pre-adipocytes can transdifferentiate into macrophages 12,13. 
Secondly, the fat body in Drosophila melanogaster  constitutes the functional unit that activates 
both metabolic and immune responses, suggesting that they evolved from a common ancestral 
structure 14,15. A third consideration is that nutrition was inevitably linked to the activation of the 
immune response, as food and water were heavily contaminated with microbial stimuli for the 
majority of human evolution. A forth line of evidence is the activation of the innate immune 
response when food is ingested. This activation is called postprandial inflammation and it is part of 
the adaptive response to meals as inflammatory markers increase after ingestion of food through 
several molecular mechanisms 14,16. Lastly, during infection a change in leptin synthesis and a 
reduction in food intake occur, reducing the probability of ingesting other pathogens and activating 
energy-requiring mechanisms (such as the digestive processes) and reducing the probability that 
epitopes from nutrients will compete for receptors crucial for pathogen sensing 17. Moreover, 
chronic infection and inflammation are linked to insulin resistance, which reduces the intracellular 
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levels of glucose (glucose is required by most pathogens for replication) and optimizes energy 
allocation to the brain (the human brain is particularly large and has a high metabolic cost) to 
protect the brain during stress stimuli, such as starvation and infections 18–20. Insulin resistance and 
storage of fats as adipose tissue might have favoured human survival because under stressful 
conditions, such as starvation or infections, peripheral cells (such as muscle cells)  shift to use fats 
as their energy substrates and insulin resistance results in glucose only being used as a substrate for 
crucial organs, such as the brain, in which it is the preferred substrate 21.  
The co-evolution of the immune and metabolic systems is also supported by data on low-grade 
chronic infections in ageing. Here we will focus on data from studies about cytomegalovirus 
infection22, which is an example of a common chronic infection associated with accelerated 
immunosenescence [G] and age-related diseases according to several immunological, clinical and 
epidemiological studies23,24 . Human cytomegalovirus persists as a lifelong infection alternating 
processes of reactivation and latency and cytomegalovirus infection  can simultanenously alter lipid 
and glucose metabolism 25,26. In the context of T2DM (a common age-related disease) an 
observation that could be predicted with an understanding of evolution is that cytomegalovirus 
seropositivity in the very elderly is associated with increased diagnoses of T2DM , leading to the 
hypothesis that cytomegalovirus seropositivity might facilitate the onset of T2DM in the long term  
27. Cytomegalovirus accelerates immunosenescence by promoting a pro-inflammatory environment 
28. This pro-inflammatory state has deleterious effects on pancreatic β-cells, which could lead to an 
insufficient response to insulin resistance, resulting in the onset of T2DM 29. Cytomegalovirus 
resides in pancreatic β-cells without apparently causing cytopathic effects, but it can influence 
insulin production directly after repeated reactivations, thus impairing insulin metabolism and 
potentially leading to T2DM  30,31. The systemic inflammation resulting from the activation and 
reactivation [G] of the cytomegalovirus, might be a biological process contributing to glucose 
regulation in the elderly. However the association between CMV infection and glucose metabolism 
in the elderly need to be further investigated since other study reported no association between them 
24. Contrasting data regarding CMV infection and glucose metabolism could derive from the 
profound differences in the prevalence of CMV infection in different populations, likely resulting in 
different adaptive mechanisms and phenotypes. Moreover experimental data adressing the effect 
that infections have on inflammaging and age-related diseases, including metabolic diseases, 
remains incomplete.  
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[H2] Degeneracy of damage sensors 
Biological degeneracy is defined as ‘the ability of structurally different elements to perform the 
same function’, and it is recognized as one of the most prominent characteristics of biological 
complexity 32 . Degeneracy (also termed ‘promiscuity’) refers to the many structures–one function 
paradigm, where in a system composed of degenerate elements, if one fails other elements can take 
over its function 32. Edelman and Gally33 provided a list of examples of degeneracy at different 
levels of biological organization, such as the genetic code, the protein folding process, metabolism, 
immune responses and connectivity in neural networks.	Experimental evidence shows that the same 
sensors such as pattern recognition receptors including Toll-like receptors (TLR) 34, NOD-like 
receptors and cyclic GMP–AMP synthase (cGAS), aryl hydrocarbon receptor (AHR) and taste 
receptors (described in BOX 1), among others, have overlapping characteristics. These receptors, 
present in the nucleus, cytosol and plasma membrane, are able to recognize self molecules (termed 
damage-associated molecular patterns (DAMPs) such as cell debris and misplaced or altered 
molecules), non-self viral and bacterial products (pathogen-associated molecular patterns (PAMPs)) 
and nutritional and metabolic products from the gut microbiota (which could be considered as 
quasi-self) 6. Pattern recognition receptors are evolutionarily conserved from insects to vertebrates, 
and their primitive function was probably to provide anti-microbial immunity and to regulate 
autophagy 34. During evolution, this array of receptors was optimized to increase inflammation and 
insulin resistance as a first response to nutrient deprivation (as autophagy is a cellular strategy to 
survive a decrease in nutrients by consuming intracellular constituents) serving at the same time as 
a strategy to combat pathogens. Thus, a situation shaped by evolution emerges, where a variety of 
different molecular motifs and stimuli  (including nutritional stimuli) converge on a small number 
of sensors that are capable of triggering the innate immune response, causing inflammation and 
concomintantly an adaptive metabolic response to environmental (external or internal) stimuli 
10,35,36 . A study published in 2017 shows that the activation of STING- dependent type I interferon 
response reduces the reactivity of microglia (tissue-resident macrophages in the central nervous 
system) and neuroinflammation, suggesting that the levels of activation of damage sensors are 
critical to have beneficial (low inflammation) or detrimental (excessive inflammation) effects 37 . 
Within this scenario inflammaging is the unpredicted consequence of the evolution-driven 
degeneracy of damage sensors that can be depicted as bow tie architecture 32 (FIG. 2A). “Bow tie” 
is a recent concept that tries to grasp the operational and functional architecture of complex 
systems. This kind of architecture has been observed in the structural organization of organisms 
throughout the biological scale, including in metabolic networks 38. The main characteristic of bow 
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tie architecture is its ability to converge a wide range of inputs (fan in) on a evolutionary-reduced 
set of building blocks (core) capable of converting them into a wide variety of outputs (fan out). In 
particular, in Fig.2 the fan in is represented by the large variety of self, quasi-self and non-self 
damage stimuli which have the capability to bind to a limited number of evolutionary-conserved 
innate immunity sensors (core), whose activation produce a large number of inflammatory 
compounds (fan out).  
There are several examples of this degeneracy or promiscuity in immune-response receptors that 
can also be activated by compounds in nutrients. One such example is the ability of saturated fatty 
acids to activate both TLR2 and TLR4, which are involved in pathogen recognition and activation 
of the innate immune response, and trigger the release of proinflammatory mediators 39,40. Another 
example is that the organic compounds curcumin (from turmeric), helenalin (extracted from 
Arnica), cinnamaldehyde (from cinnamon) and sulforaphane (extracted from cruciferous 
vegetables, such as broccoli), containing α,β-unsaturated carbonyl or isothiocyanate group, can 
inhibit TLR4 activation by interfering with TLR4 receptor dimerization 41. In addition, gliadin (a 
component of gluten) can activate the TLR signalling pathway in vitro 42. Furthermore, morphine 43, 
glucuronic acid (found in natural gum), the ethanol metabolite ethyl-glucuronide 44, polyphenol 
epigallocatechin-3-gallate (found in green tea) 45, phenethyl isothiocyanate (found in cruciferous 
vegetables) and parthenolide (extracted from the plant, feverfew) can all activate TLRs 46. Finally, 
during ageing a diet rich in saturated fatty acids activates pattern recognition receptors, and together 
with debris from dead cells (necroptosis) 47 which behave as DAMPs activate an inflammatory 
response that is similar to that seen during an infection.  
A study published in 2016 showed that self nucleic acids and nucleic acid sensing receptors have a 
fundamental role in promoting inflammation associated with diet-induced obesity and in the 
regulation of glucose homeostasis and insulin signalling in obesity 48. Diet-induced obesity 
promotes excess release and diminished clearance of nucleic acids, and mishandling of nucleaic 
acids activates visceral adipose tissue macrophages, via TLR7 and TLR9, to promote inflammation. 
Moreover, inhibiting TLR7 and TLR9 improves obesity-related inflammation and glucose 
homeostasis. Another study showed that obesity-related adipocyte degeneration causes the release 
of single-stranded and double-stranded cell-free DNA into the plasma, which promotes macrophage 
accumulation in adipose tissue (via TLR9 activation) and stimulates chronic adipose tissue 
inflammation and insulin resistance 49. The degeneracy of TLR9 sensing of mitochondrial DNA 
(mtDNA) is described in BOX 2.  
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[H2]  Stimuli that fuel inflammaging 
A major focus in ageing research is the identification of the stimuli that fuel inflammaging. A 
variety of data suggests that besides persistent viral (such as CMV) and bacterial infections (such as 
periodontitis infections 50), cell debris, misplaced self-molecules and misfolded and oxidized 
proteins are major contributors to inflammaging 36,51. Within this framework, the gut microbiota is 
of particular and crucial importance as it is at the boundary between diet, metabolism and the innate 
immune response 52 and also because it undergoes profound remodelling with age 53–56. Host–
bacteria symbiosis (in particular the co-evolution of the gut microbiota and its human host), 
preserves the mutually advantageous co-existence where the host gains nutrients from the digestion 
of certain foods by the microbiota and the commensal microbiota feed on the host’s meals. As 
beneficial and potentially pathogenic microbes share similar epitopes, evolutionary forces provided 
by the microbiota itself might have shaped many immunological features in the host in order to 
produce mechanisms of immunological tolerance 57–59. 
The human gut microbiota is a highly diverse ecosystem made up of trillions of bacteria that 
establish a complex, multi-species ‘new organ’. Every component of this ecosystem has a specific 
role and is capable of responding to signals from its host or the environment (including the 
circadian rhythm; BOX 3) by altering its own activity 60. There are several factors that can 
permanently change the composition and function of the gut microbiota, which results in large 
variabilities and heterogeneity of this ecosystem in the human host 61. These factors that constitute a 
sort of biography of each person are divided into individual-based (age, gender, genetics, lifestyle, 
type of delivery, breastfeeding or formula feeding), population-based (ethnicity, cultural habits, 
nutrition, population genetic structure and ancestry), and environment-based (climate, use of 
antibiotics, immunological stimuli lifelong). The adaptive and plastic nature of the gut microbiota 
allows it to adjust the host’s immune and metabolic pathways in response to dietary habits and 
energy requirements and it has a profound effect on health and disease 60. The gut microbiota has a 
central role in immunity and metabolism due to its pervasive effect and continuous crosstalk with 
the other organs and tissues of the body. The intestinal immune responses during health and disease 
are shaped by the gut microbiota and the age-related remodelling of it might contribute to systemic 
inflammaging, which can directly or indirectly affect its composition in a self-sustaining loop 62 
(FIG. 3A). In particular, the changes in the gut microbiota profile in centenarians, where there is an 
enrichment of Proteobacteria and a decrease in butyrate-producing bacteria, correlate with a 
systemic increase in levels of the pro-inflammatory cytokines IL-6 and IL-853. Proteobacteria is a 
group containing many of those bacteria recently redefined as ‘‘pathobionts’’. These are considered 
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to be minor and opportunistic components of the human gut ecosystem that, under some 
circumstances, e.g. inflammation, may escape surveillance, overtake mutualistic symbionts and 
induce pathology. Butyrate is a short chain fatty acids representing a major energy source for the 
enterocytes and has been implicated in the protection against inflammatory bowel diseases 44. 
Studies in mouse models showed that when gut microbiota from aged mice was inoculated into 
young germ free mice it induced inflammaging, increased the percentage of several T helper (TH) 
cell subsets and the levels of inflammatory markers, such as TNFα  63,64. This pro-inflammatory 
effect was associated with lower levels of Akkermansia (a well-known health-associated genera 
protecting against inflammation, and promoting a healthy metabolic homeostasis 65), and higher 
levels of TM7 bacteria and Proteobacteria (both associated with intestinal inflammation and the 
pathogenesis of Intestinal Bowel Disease 66,67), which is probably linked with the increased 
inflammatory potential of the gut microbiota of aged mice 63.  
A comprehensive phylogenetic analysis of the human gut microbiota  of individuals from Italy 
(aged 22–109 years) showed that the core population of gut microbiota (which is comprised of the 
dominant symbiotic bacterial taxa Ruminococcaceae, Lachnospiraceae and Bacterodaceae) 
exhibits a decrease in diversity and relative abundance with age 56. In extreme longevity (over 105 
years), this decline is offset by an increase in longevity-adapted, and possibly beneficial, 
subdominant species of Akkermansia, Bifidobacterium and Christensenellaceae. Accordingly, an 
unexpected increase in diversity in the composition of the gut microbiota in comparison with young 
subjects was observed in centenarians from Italy, and also in those from China and Japan despite 
the differences in genetics, lifestyle and diet between people from these countries 60. Such a 
remarkable signature of longevity, per se, is probably a key health indicator of centenarians, at 
variance with the charactersistic decrease in gut microbiota diversity that is associated with most, if 
not all, age-related diseases 56,60. 
 
[H2]  Stimuli that attenuate inflammaging  
 
[H3] Calorie restriction 
Evolution favours the emergence of mechanisms and phenotypes that ensure survival when faced 
with undernutrition or starvation, while countermeasures against energy or nutrient excess 
apparently do not develop 68. This feature is probably why calorie restriction (by reducing calorie 
intake or alternate fasting) elicits conserved cell protective responses in nearly all tissues and organs 
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that extend the lifespan of simple model organisms, mammals and non-human primates 69. As with 
all experiments, there are several variations and exceptions in the longevity models, which could be 
due to differences in strain or genetic background of the animals used, feeding regimens, diet 
composition (the ratio of protein: carbyohydrate: fat; natural or purified ingredients), age of onset 
(the age at which the calorie restriction was implemented), laboratory differences and other 
variables 69. Overall, the results suggest that the effect of calorie restriction is highly conserved, 
even in mammals, and involves common pathways across phyla and species 70.  
There is a consensus that calorie restriction involves the down-regulation of insulin, insulin-like 
signalling, the mammalian target of rapamycin (mTOR)–ribosomal protein S6 kinase (S6K) 
pathway and glucose signalling through Ras–protein kinase A (PKA) pathway as well as the 
activation of NAD-dependent protein deacetylase sirtuin 1 (SIRT1) 71. These pathways activate 
autophagy, stress defence mechanisms and survival pathways while attenuating pro-inflammatory 
responses 72. Calorie restriction has been proposed to activate these longevity-promoting pathways 
by acting as a mild stressor that promotes hormetic responses 73. Major targets of calorie restriction 
are mitochondria, which undergo a mild functional impairment, which, counter-intuitively, results 
in the promotion of longevity by crosstalk with the nucleus and secretion of a variety of mitokines 
(such as FGF21, GDF15 and humanin) 74. Different types of macronutrient restriction exist, but the 
reduction of dietary proteins and amino acids is most effective for promoting longevity 75. In 
particular, dietary restriction of a single essential amino acid in a normal diet is able to increase 
lifespan. For instance, a tryptophan-restricted diet, which can promote longevity and reduce the 
effects of age-dependent deterioration, has been explored for its neurological benefits as tryptophan 
has a role in serotonin synthesis 71. A general reduction of inflammation in the body is apparently a 
major advantage of calorie restriction, resulting in pervasive beneficial effects on ageing 
mechanisms (including insulin resistance, adult neurogenesis and neuronal plasticity, autophagy and 
mitochondrial biogenesis) 76. In summary, cells perceive the reduced availability of nutrients and 
translate this information into integrated, adaptive or protective metabolic and immune responses. 
The relationship between nutrient intake and inflammatory processes is summarized in FIG. 2B. 
[H3]  Hibernation 
Life-extending manipulations, such as calorie restriction, also decrease core body temperature. 
Temperature is a basic and essential property of any physical system, including living systems. 
From poikilotherms (organisms that cannot regulate their own body temperature) to homeotherms 
(organisms that can maintain thermal homeostatsis) there is a clear trend that animals with naturally 
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lower body temperatures have longer lifespans than those with higher body temperatures , both in 
wild animal populations and under laboratory conditions 77. In 1997, a study suggested that the 
body’s response to calorie restriction in mammals shows features similar to hibernation and 
concluded that the observations from calorie restriction studies conducted by gerontologists is due 
to a range of evolution-conserved responses to food deprivation and not a result of laboratory 
artifact 78. The study suggests that the responses have adaptive value in the wild and activation of 
these mechanisms might involve the neuroendocrine system. 
The previously discussed evolutionary-driven hierarchical redistribution of energy 20, which is a 
response to situations of undernutrition, starvation and infections, is a good example showing the 
similarities shared between hibernation, which involves complex neuroendocrine remodelling, and 
calorie restriction 78 for extending lifespan. On the physiological level, the similarities between 
fasting during hibernation and calorie restriction are manifested in several ways, for instance, 
decrease in blood glucose and blood insulin levels 78. Fasting mice are prone to reduced body 
temperatures and enter a torpor-like state. Calorie restriction in mice and hibernation in the Arctic 
ground squirrel share many similar molecular signatures that are involved in shifting metabolic fuel 
use79. Examples of these signatures include the high expression of genes involved in 
gluconeogenesis and the low expression of genes involved in fatty acid biosynthesis, together with 
regulatory changes that suppress cell growth; all these changes seem to be largely driven by 
peroxisome proliferator-activated receptor α (PPARα)79. Changes to the expression of genes 
involved in the sleep–wake cycle-related and temperature response such as heat shock proteins and 
cold-inducible RNA-binding protein (CIRBP) led to the hypothesis that the torpor–arousal cycle is 
the result of the expression of peripheral clock genes situated in peripheral tissues but not the 
central circadian clock genes within the suprachiasmatic nuclei (SCN) of the hypothalamus, that 
persists in a non-temperature compensated manner during hibernation (core clock genes are arrested 
and stop oscillating during hibernation) 80 . Circadian oscillations are indeed generated by a set of 
genes forming a transcriptional autoregulatory feedback loop. In mammals, these include: Clock, 
Bmal1, Per1, Per2, Cry1, and Cry2 81. 
[H1] Inflammaging and metaflammation  
[H2] Nutrition and Inflammation 
The most advanced and convincing mechanism linking nutrient excess and inflammation is the so-
called ‘metaflammation’ (metabolic inflammation) process, which is a low-grade chronic and sterile 
inflammatory status, sustained by high nutrient intake that alters the inflammatory milieu of 
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metabolic cells, tissues and organs 6. The concept of metaflammation was developed from studies 
on the effect of overfeeding in animal models5. The increase of the low-grade physiological 
inflammation  under conditions of high nutrient intake is a critical contributor to the onset of insulin 
resistance. The result is an increased activation of inflammatory responses that affects a variety of 
organs (such as the adipose tissue, liver, pancreas, muscle and brain). The basis of metaflammation 
is the physiological inflammatory activation elicited by the ingestion of any meal (where lipids have 
a central role) by an organism (BOX4). Postprandial lipoproteins are involved in the inflammatory 
process that preceeds the development of cardiometabolic diseases (such as atherosclerotic 
cardiovascular disease, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and T2DM). 
During the postprandial state, remnants of chylomicrons and VLDL (also called triglyceride-rich 
lipoproteins) bind to endothelial cells and circulating leukocytes 82–86. The binding of the 
triglyceride-rich lipoproteins results in acute activation of the cells that elevates levels of adhesion 
molecules, cytokines, oxidative stress and ultimately fuels inflammation. Moreover, triglyceride-
rich lipoproteins and free fatty acids  (produced by the hydrolysis of triglyceride-rich lipoproteins) 
stimulate the expression of vascular cell adhesion protein 1 (VCAM1) in human aortic endothelial 
cells, which stimulates monocytes adhesion 87–89. 
[H2] Bacterial endotoxins 
During a state of nutrient overload and excessive exposure to meals rich in pro-inflammatory fatty 
acids the innate immune system is exceedingly stimulated, which contributes to homeostatic failure 
(which is loss of capacity of the cells to properly respond to changes of the external environment) 
that in turn leads to metabolic disorders. High-fat meals in healthy subjects results in an increased 
neutrophil count and raised levels of IL-6 and hydroperoxides 90. In healthy individuals, a high-fat 
diet also increases serum levels of bacterial endotoxin (lipopolysaccharide), which might cause 
leukocyte activation and inflammation 91. Bacterial endotoxins are potent inflammatory compounds 
that circulate at low concentrations in the blood, which mimics a sort of chronic low-grade bacterial 
infection. The abundance of bacterial endotoxins in the gut depends on which bacteria are present. 
Postprandial elevation of lipopolysaccharide in the circulation contributes to ‘metabolic 
endotoxemia’ (which is defined in this way because initiated by the food intake and not by a 
primary infection by bacteria) and low-grade inflammation 92, which seem to have a substantial  
role in the development and progression of cardiometabolic diseases 93 and in promoting ageing 
phenotypes (such as muscle decline and sarcopenia)94. A high-fat diet can cause gut microbiota 
dysbiosis that exaggerates the physiological production of lipopolysaccharide and dysregulation in 
meal timing contributes to such metabolic and inflammatory dysregulation (BOX 3).  
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[H2] Adipocytes 
From a mechanistic point of view adipose tissue is at the core of metaflammation. Adipocytes 
exposed to nutrient-dense diets increase in size until they reach a structurally critical condition 95 . 
Consequently, vascularization of adipose tissue is reduced and adipocytes are exposed to hypoxic 
conditions. Moreover, obese mice adipocytes  experience endoplasmic reticulum (ER) stress caused 
by the accumulation of unfolded proteins with the concomitant activation of the mTOR pathway 
and downregulation of AMP-activated protein kinase (AMPK) and SIRT pathways 96,97. Thus, ER 
stress triggers inflammation through the activation of the unfolded protein response 98. 	
[H2] Similarities 
The similarities and differences between inflammaging and metaflammation were comprehensively 
reviewed in 2017 99. The concepts of metaflammation and inflammaging emerged from two distinct 
research fields — the obesity and T2DM and the ageing and longevity field, respectively. However, 
few, if any, studies exist that cover both metaflammation and inflammaging or in which 
inflammaging originally observed and conceptualised in humans 100 has been mechanistically 
modelled and validated in animal studies. On the other hand metaflammation stems from study on 
animal models that identify mechanistic relationship between nutrient excess and increase in the 
inflammatory paths disregarding the role of inflammaging. It is remarkable that these two broad 
research fields have identified — independently and almost simultaneously — that a chronic and, 
most importantly, sterile inflammatory process is the critical aetiological momentum for metabolic 
diseases and age-related physiological decline, thus likely playing a critical role in all the major 
age-related diseases. It is also noteworthy that, although the stressors that are the basis of these 
inflammatory processes are different, the mechanisms that sustain chronic inflammation are largely 
shared by inflammaging and metaflammation. Indeed, the following processes all have a central 
role in inflammaging and metaflammaging: the increase of senescent cells and their accumulation; 
hyperactivation of the innate immune response through TLR signalling, inflammasome and cGAS–
STING (Cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) detects 
intracellular DNA and signals through the adapter protein STING (stimulator of interferon genes)) 
pathway activation; and the accumulation and systemic spillover of cellular debris as a consequence 
of the exacerbation of cell death in target tissue and organs and mitochondrial dysfunction. 
Accordingly, metaflammtion can contribute to inflammaging and be considered a nutrient excess-
driven accelerated ageing, supporting the conceptualizationof a continuum of ageing and age-
related diseases 101. 
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Both metaflammation and inflammaging, separately and/or together, exert a pro-inflammatory 
systemic effect, which suggests that both phenomena can interact and synergize and probably 
interfere with inter-organ communication and crosstalk. Understanding the inter-organ interaction 
represents one of the most intriguing and complex scientific issues that needs to be urgently 
addressed. The ‘garbaging theory’, proposed in 2017, goes to the heart of this issue from an ageing 
and age-related diseases perspective 36. ‘Garbaging’ proposes that, besides persistent viral and 
bacterial infections, inflammaging is largely caused and sustained by the age-related progressive 
impairment of the ‘cleaning’ of misplaced and/or damaged self-molecules (cell debris) produced by 
the physiological or pathological cell death processes 36,51. The systematic study of circulating 
mediators such as microRNAs 102, micro-vesicles 103, nano-vesicles and lipids in the elderly and 
during nutrient excess conditions could help in understanding how the communication between 
organs and tissues is altered by inflammaging and metaflammation, and if and how such alterations 
subsequently contribute to sustain chronic age-related and metabolic diseases.   
 
[H1] Integration of biomarkers 
The unifying hypothesis that metaflammation might precede and contribute to inflammaging and 
vice versa, and that metabolic age-related dysfunctions and diseases could be considered 
manifestations of the acceleration of ageing (which in turn accelerate ageing itself) opens a new 
possibility regarding biomarkers that could and should be used to assess most metabolic diseases. In 
metabolic diseases, it is timely to apply a new set of informative and robust biomarkers that have 
emerged from studies of human ageing and can be used to measure the ‘biological’ age of 
individuals compared with their chronological age. The new markers should be integrated with the 
classic biochemical and hormonal parameters, including lipids as biochemical markers of immune-
metabolic dysregulation.  The following sections will describe in detail three biomarkers, while an 
overall summary of the biomarkers is reported in Table 1. 
[H2]DNA methylation 
A general alteration of the chromatin structure and the epigenetic signature of the genome is a major 
characteristic of the ageing process, which can be assessed by the newly available techniques that 
can scan the whole epigenome. DNA methylation is a biomarker that can be used to distinguish 
chronological age from biological age. To date, the biomarker that gives the best correlation with 
chronological age in humans is the DNA methylation levels of the CpG sites located in a CpG 
island in the promoter region of ELOVL2 (which encodes omega 3 and omega 6 fatty acid elongase, 
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also known as ELOVL fatty acid elongase 2) 104. However, studies from the past 7 years have 
developed a mathematical model (termed ‘epigenetic clock’) based on the DNA methylation levels 
of many CpG sites  to estimate the biological age of individuals 105–108. The epigenetic clock has 
been applied to different conditions. The most studied model is Horvath’s epigenetic clock, which is 
based on the DNA methylation levels of 353 CpG sites across the human genome. Results from 
using the epigenetic clock provide information about the biological age of individuals, which could 
be associated with their health status and used to predict the potential occurrence of age-related 
health outcomes.  
For instance, using the Horvath’s clock on patients with Down syndrome or Werner syndrome (a 
rare adult premature ageing disease), the epigenetic clock showed an age acceleration for both 
conditions 109–111, while in centenarians and their offspring, the clock showed a consistently 
decelerated DNA methylation age 112. To date different measures of epigenetic acceleration exists 
113and measuring the extrinsic epigenetic age acceleration allows the measurement of epigenetic 
ageing in immune-related components having a positive correlation with the amount of exhausted 
CD8 T cells and plasma blast cells)  and predicts risk factors for cardiometabolic disease. 
Moreover, the analysis of extrinsic epigenetic age acceleration in post-menopause women between 
ages of 50 and 79 years enrolled in the WHY study (women's Health Initiative) showed a positive 
correlation with triglyceride levels, C-reactive protein  and creatinine, and a negative association 
with education levels  114. In a 2017 study, a mouse epigenetic clock, constructed from blood DNA 
methylation profiles, correctly estimated the biological age of a mouse cohort. This mouse clock 
was also able to measure the effect of calorie restriction and of knockout of specific gene on ageing 
and detect the rejuvenation of fibroblast-derived induced pluripotent stem cells 115. To date, the 
relationship between DNA methylation-age (age determined by DNA methylation levels) and 
inflammaging have not been investigated. Studying the possible relationship of these two factors is 
of the utmost interest. The correlation between cytomegalovirus infection and higher methylation 
levels of ELOLV2 provides evidence of a possible interaction between these factors 116. Several 
studies that offer indirect observations on this subject showed a possible link between whole blood 
DNA methylation levels (in different CpGs sites) and plasma levels of different pro-inflammatory 
compounds (such as serum C-reactive protein or plasma IL-6 levels) 117–119 or chronic inflammatory 
conditions 120 .  
 
[H2]Glycomics  
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Glycosylation is a frequent co- and  post-translational modification of proteins which modulates a 
variety of biological functions including their conformation, solubility, antigenicity, activity, and 
recognition by glycan-binding proteins. The analysis of the sugar chains attached to protein at 
asparagine (Asn) residues by an N-glycosidic bond (N-glycans, collectively called N-glycome) 
identified new candidate biomarkers of aging such as N-glycans devoid of galactose residues on 
their branches121.   Since the two seminal studies by Vanhooren and colleagues122,123, enzymatic 
glycosylation has become one of the most promising biomarkers of biological age. The two studies 
demonstrate that the log-ratio of the relative abundance of two N-linked glycan species (namely 
agalacto, core-α-1,6-fucosylated diantennary glycan, NGA2F and  digalacto core-α-1,6-fucosylated 
diantennary glycan, NA2F) increases progressively with age and is  associated with features of 
healthy and unhealthy ageing. This combination of N-linked glycan signals was called ‘GlycoAge 
test’ and was tested in a number of  human pathological conditions (Down syndrome, T2DM, 
hepatocellular carcinoma) to assess its ability to determine features of biological age. Of all the 
studies that tested GlycoAge, the result worth mentioning is the report of an accelerated glycomic 
age for individuals with Down syndrome, which is similar to the results from DNA methylation 
analyses 124.  
 
Technological advancements has made it possible to measure the whole spectrum of N-linked 
glycans from peripheral tissues, such as serum or plasma 125  . In 2013, the use of N-glycans as a 
biomarker of inflammaging in the elderly was proposed121. Protein galactosylation is responsible for 
the anti-inflammatory function of IgG; thus when  the galactosylated biantennary structures that  
decorate the Asn297 of Fc portion of IgG become with age devoid of galactose at both branches 
they are called IgG-G0 and become highly pro-inflammatory.  In particular, the study proposed to 
use IgG-G0 as a biomarker of inflammatory conditions during ageing, where chronic low-grade 
inflammatory pathways negatively affect the glycosylation machinery of antibody-producing cells. 
The accumulation of IgG-G0 together with the loss of a2,6-sialilation of IgG glycans during ageing 
can contribute to inflammaging and to age-related diseases as they exert a pro-inflammatory effect 
through different  mechanisms involved in inflammation and in process that sustain and amplify 
inflammatory signals including activation of the lectin pathway of complement  through the 
mannose-binding lectin pathway,  phagocyte activation by binding to Fcγ receptors, formation of 
autoantibody aggregates. Moreover, glycosylation promotes the recognition by DC-SIGN (dendritic 
cell-specific intercellular adhesion molecule-3-grabbing non-integrin) which increases expression of 
inhibitory FcγRIIB and is anti-inflammatory. Within this framework, age-related alterations of the 
N-glycome were suggested as a biomarker of biological age and inflammaging 121,124.  
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A study published in 2014  confirmed and extended the application of glycans as a biomarker of 
biological age 126 . The study includes data on the IgG glycosylation of 5,117 individuals from four 
European populations (Croatia island Vis, Croatian island Korcula, Orkney Island in Scotland and 
United Kingdom). The study showed that several IgG glycans promoting inflammation (including 
FA2B, FA2G2 and FA2BG2) account for up to 58% of the variance in chronological age 
(considerably more than other biomarkers of age like telomere lengths), while the remaining 
variance strongly correlated with physiological parameters associated with biological age and 
metabolism (systolic and diastolic blood pressure, forced vital capacity and peak expiratory flow, 
albumin, waist circumference,  BMI, glucose, insulin, cholesterol, triglycerides, LDL, HDL, 
creatinine and uric acid. . The association of IgG N-glycan variability with critical parameters, 
including the metabolic ones, to assess health status and burdens in the elderly is extremely 
promising and support the specific IgG N-glycan analysis to obtain innovative and informative 
markers to monitor health in elderly population. Following the hypothesis that protein glycosylation 
should predict higher cardiovascular risk by reflecting inflammatory pathways a study published in 
2018 on 76 IgG glycosylation traits in 2970 women (age range, 40-79 years) from the TwinsUK 
cohort and  replicated in 967 women from ORCADES cohort (Orkney Complex Disease Study) 
reported that glycosylation traits are independently associated with arterial lesion formation and 
subclinical atherosclerosis while one specific trait related to the sialylated N-glycan (GP18-the 
percentage of FA2BG2S1 glycan in total IgG glycans) is negatively correlated with cardiovascular 
disease risk, very-low-density lipoprotein and triglyceride serum levels, and presence of carotid 
plaque 127. 
 
Available data also showed that the IgG N-glycosilation changes observed with ageing could be 
related not only to inflammation but also to the alteration of important metabolic parameters and 
pathways 121. The first study on the relationship between  metabolic diseases such as metabolic 
syndrome and  T2DM and N-glycans was that of Testa and colleagues 128 on 562 T2DM patients 
(mean age 65.6±8.2 years) and 599 healthy control subjects (mean age, 58.5±12.4 years). Specific 
and significant changes in N-glycan composition in the sera of T2DM patients and in T2DM with 
complications  were found. In particular, α (1,6)-linked arm monogalactosylated, core-fucosylated 
diantennary N-glycans (NG1(6)A2F) were significantly reduced in T2DM compared with control 
subjects. Macro vascular-complications were found to be related with decreased levels of 
NG1(6)A2F. Moreover, NG1(6)A2F and NG1(3)A2F levels were strongly negatively correlated 
with most of metabolic syndrome parameters (waist/hip ratio, triglycerides, glycemia, glycated 
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haemoglobin and the absolute number of neutrophils) while NG1(6)A2F levels are negatively 
correlated with HOMA and NG1(3)A2F levels are positively correlated with HDL. Furthermore 
NG1(6) A2F and NG1(3)A2F decrease more with the increased severity of patient phenotype from 
the extreme “healthy” (controls without MS) to the extreme “unhealthy” (T2DM+ with metabolic 
syndrome) 128 . 
In a randomized, single-blind, placebo-controlled trial, 38 prediabetic subjects received metformin 
(1500 mg/day) or placebo for 2 months. Metformin significantly improved insulin sensitivity and 
metabolic parameters compared to baseline and favourably modified the plasma N-glycan profile 
compared to placebo 129 . On the same line, Keser and colleagues reported that increased 
complexity of plasma N-glycan structures is associated with higher risk of developing type 2 
diabetes and poorer regulation of blood glucose levels 130. Another study published in 2017 on a 
cohort of 1826 individuals demonstrated the potential of IgG1, IgG2 and IgG4 glycosylation as a 
biomarker for inflammation and metabolic health 131. The results  showed that a low level of 
galactosylation and sialylation and a high degree of core fucosylation associated with poor 
metabolic health and increased inflammation as assessed by increased C-reactive protein, low 
serum HDL and high triglycerides. 
Finally, it is interesting to note that up to 50% of plasma glycome variability is estimated to be 
herirtable and a genetic control of IgG glycosylation is suggested by a genome-wide association 
study (GWAS) on liquid chromatography electrospray mass spectrometry (LC-ESI-MS)-measured 
IgG glycopeptides of 1,823 individuals in the Cooperative Health Research in the Augsburg Region 
(KORA F4) study cohort and replicated in 1,836 individuals from the Leiden Longevity Study 
(LLS). The results indicate that, in addition to genes encoding for glycosyltransferases (i.e., 
ST6GAL1, B4GALT1, FUT8, and MGAT3), other genetic loci have strong influences on the IgG 
glycosylation patterns, including the transcription factor RUNX3 132.  
As a whole, the age-related increase in aberrantly glycosylated IgG and other proteins can be taken 
as a robust marker of biological age and a factor contributing to inflammaging  by its capability to 
activate the immune system toward a pro-inflammatory status. 
 
[H2] Metabolomics and lipidomics 
Metabolomics [G] and lipidomics [G]could provide biomarkers at the interface between 
metabolism, inflammation (including age-related changes in the composition of the gut microbiota) 
and disease risk. The use of high-throughput technologies, such as liquid chromatography tandem-
mass spectrometry (LC-MS) and NMR allow the measurement of a wide range of endogenous 
small-molecule metabolites. A study published in 2014 showed for the first time that lipidomics 
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could be a possible source of biomarkers of biological age and longevity 133. The researchers 
showed that centenarians had a peculiar lipid profile, with unique changes in 41 of 161 measured 
lipid species. The lipid profile  emphasized that long-living individuals have marked features of 
anti-inflammatory molecules, such as increased levels of phenylalanine, which inhibits the nuclear 
factor-κB (NF-κB) pathway, and decreased levels of glycerophosphocholine (a circulating marker 
of cellular senescence). Moreover, the use of lipidomics in a longevity study was reported in 2013;  
19 lipid species associated with female familial longevity were identified134. A profile that included 
high levels of phosphocholine and sphingomyelin and low levels of phosphoethanolamine and long-
chain triglycerides species was found to be characteristic of healthy ageing. The study suggests that 
the longevity plasma lipidome reflects the antioxidant capacity, lower lipid peroxidation 
inflammatory state and β-oxidation function  likely contributing to healthy aging of studied 
individuals. Additionally the same study reported several longevity-associated lipids that correlated 
with a reduced risk of age-related diseases, such as hypertension and diabetes mellitus.  
Several studies have successfully used metabolomic profiling to identify biomarkers of metabolic 
diseases, such as T2DM 135–137 and obesity 138,139 . The metabolomic profile of extreme ageing was 
described in a study published in 2013 52. In this study, the comparison of NMR metabolomic 
profile from a cohort of centenarians and their offspring from Italy with the profiles of adults and 
young controls showed for the first time that from a young age to extreme longevity the relative 
concentration of analysed metabolites change with age with different trajectories. Centenarians 
plasma and urine  showed changes in the levels of  specific glycerophospholipids and sphingolipids 
and a decrease in tryptophan concentration 52. The metabolomic profile of centenarians showed 
peculiar mechanisms of cellular detoxification, which was through the specific modulation of the 
arachidonic acid metabolic cascade and enhanced cytochrome P450 enzyme activity. In particular, 
the longevity phenotype of arachidonic acid synthesis displayed both pro-inflammatory and anti-
inflammatory characteristics, such as a high concentration of leukotriene E4 (a molecule with 
vasodilatation properties) or a high concentration of 15-hydroxyeicosatetraenoic acid (a molecule 
with anti-inflammatory properties). This metabolomic profile is in line with the hypothesis that 
longevity results in complex remodelling of lipids, amino acid metabolism, and of gut microbiota 
Similarly, the metabolomic profile of centenarians was successfully correlated with the 
metagenomic profiles of semi-supercentenarians (105 years of age or above) in another study56 . 
These results highlight that the different classes of biomarkers are tightly interconnected, as shown 
by a study published in 2016 that suggested that blood lipids influence in circulting cells  140. The 
data suggest that by combining the different classes of molecules (e.g. DNA methylation status of 
specific genomic loci with tiglicerides levels) it is possible to obtain a new generation of biomarkers 
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that are effective in assessing health status in   different domains of biological ageing and can be 
used to predict healthy and unhealthy ageing.  
 
Such an approach, with the inclusion of validated metabolic health biomarkers, should help to 
improve the accuracy of identifying individuals who do not have overt metabolic disease, but who 
have pre-clinical alterations of metabolism and accelerated ageing — a preventative and  
personalized approach. These new biomarkers will also be useful in monitoring the efficacy of 
therapeutic interventions, including diet 141, physical exercise, prebiotics and probiotics. The 
relationship between local and systemic inflammaging and metaflammation in the onset of chronic 
age-related diseases is still unclear and represents a major challenge and research subject that will 
be critical for the identification of additional biomarkers. 
 
[H1] Conclusions  
Collectively, the nutrient composition and the quantity of meals, as well as when meals are eaten 
(timing, rhythmicity), have a strong effect on the gut microbiota and metabolism, thus contributing 
to sustain basal level of inflammation ("inflammatory tone" 4) which can be increased by over-
nutrition (metaflammation) and ageing (inflammaging). Accordingly, metaflammation (caused by 
nutrient excess) can be conceptualized as a specific case of a more general and physiological 
mechanism that encompasses the activation of the pro-inflammatory evolutionary-selected 
machinery (depicted in Figure 2), that is the activation of the innate immune system whenever 
danger signals are sensed. This physiological and unavoidable ‘inflammatory tone’ 4 that occurs in 
the young and adult increases over time and can become highly detrimental either at old age (which 
is largely unpredicted by evolution) or in a situation such as over nutrition and nutrient excess 
(which is also unpredicted by evolution). The conceptual integration of inflammaging and 
metaflammation within the geroscience perspective suggests that metaflammation can be 
considered a specific type of accelerated ageing and paves the way to the amalgamation of 
biomarkers, which until now were developed separately, thus contributing to improved preventive 
and personalized medicine for the elderly.  
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Key	points	
	
• According to geroscience, inflammation is one of the seven evolutionary-conserved 
mechanistic pillars of ageing that is shared by age-related diseases, including metabolic 
diseases. 
 
• Inflammaging is the long-term result of the chronic physiological stimulation of the innate 
immune system, which can become damaging during ageing — a period of life largely 
unpredicted by evolution  
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• Inflammaging is the byproduct of the degeneracy of a few receptors that can sense a variety 
of non-self, self and quasi-self ‘damage’ signals (or ‘garbage’) and activate the innate 
immune system.  
 
• Inflammaging and metaflammation largely share the same molecular mechanisms, where 
metaflammation can be conceptualized as a specific situation of chronic inflammation 
caused by nutrient excess.  
 
• The gut microbiota has a central role in metaflammation and inflammaging as it can release 
inflammatory products and contribute to the circadian rhythms and  crosstalk with other 
organs and systems.  
 
• Biomarkers of ‘biological’ age, such as DNA methylation, glycomics, metabolomics and 
lipidomics, can be successfully applied to metabolic diseases. 
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[b1] BOX 1- Inflammation, taste and chemosensory receptors  
Taste receptors, in particular G protein-coupled receptors, that detect bitter, sweet and savoury 
tastes, signal to the brain to orchestrate food behaviour (searching for, choosing of and consuming 
food) in response to a wide range of nutritional stimuli. The same receptors not only have a role in 
nutrient sensing, but also in immune detection and in inflammation. In the upper respiratory 
epithelium, bitter and sweet taste receptors influence antimicrobial innate immune defence 
responses. Lee and colleagues142 hypothesized that D-amino acids, produced by various bacteria, 
activate TLR in taste receptor cells in the mouth, as well as in the airway. Previous studies showed 
that the bitter receptor T2R38 in the upper respiratory epithelium can recognize epitopes produced 
by Pseudomonas aeruginosa 143, which can be taken as an example of a receptor involved not only 
in the perception of bitterness but also in host defence by sensing infection 144. TRPM5 (transient 
receptor potential cation channel subfamily M member 5), a cation channel essential for the 
transduction of bitter, sweet and umami flavours, is also expressed in intestinal cells called tuft 
cells. TRPM5-dependent signals activate tuft cells that are involved in the initiation of immune 
responses following parasitic infections by producing IL-25, which promotes the rapid expansion of 
type 2 innate lymphoid cells  145,146. In Drosophila melanogaster, environmental sensing is involved 
in lifespan duration147 and loss of pickpocket protein 28 (Ppk28), a water sensor defined as a 
gustatory gene, alters metabolic homeostasis by promoting the internal storage of lipids and water 
to extend lifespan 148. These examples show that taste receptors and chemosensory receptors 
constitute not only sensory structure for food, but it can also be hypothesized that they behave as 
pattern recognition receptors. The study of the degeneracy of these receptors and their potential role 
in modulating inflammaging and metaflammation is therefore a subject of interest for future 
research on ageing, longevity and metabolic diseases.  
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[b2] BOX 2. The degeneracy of cell-free mtDNA sensing and inflammation 
 
The capacity of the limited number of sensors depicted in Fig 2 to recognize a large variety of self, 
non-self and quasi-self molecular motifs makes them reasonable candidates for the evolutionary 
unpredicted development of inflammaging 32. A clear example of such sensor degeneracy is the 
mitochondrial DNA (mtDNA), which is normally inside the mitochondria. A great amount of cell-
free mtDNA (cf-mtDNA) can be found in the blood in a variety of pathological conditions (such as 
sepsis), as a result of cell damage and death 149. We assumed that cf-mtDNA is also an example of 
inflammatory garbage, as large amounts of cf-mtDNA are present in the blood of the elderly and 
nonagenarians 150. The amount of cf-mtDNA appears to be a familial or genetic trait and has a high 
inflammatory capability, probably due to the mitochondria’s ancestral derivation from bacteria 150. It 
is probably not by chance that mtDNA, which has characteristics of self, non-self and quasi-self 
molecules, is sensed by several of the sensors mentioned in Fig.2, such as TLR9 (Toll-like receptor 
9), NLRP3 (NOD-like receptor family, pyrin domain-containing protein 3) and cGAS-STING 151. 
This sensing redundancy is also indirect evidence that the recognition of mtDNA is biologically 
critical. In addition to mtDNA, TLR9 is also able to recognize bacterial and viral DNA, as well as 
synthetic oligonucleotides 152. Moreover, the function and expression of the previously mentioned 
sensors, all capable of activating innate immunity and inflammation, are modulated by circadian 
rhythms (BOX3), which is the case for TLR9. A study investigated the in vivo daily variations in the 
responsiveness of TLR9 to its ligand and showed that the time of day determines disease severity in a 
TLR9-dependent sepsis mouse model. Moreover, it was demonstrated that timing of immunization 
determines TLR9 ligand-adjuvant vaccine responsiveness 153. 
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[b3] Circadian fluctuation of gut microbiota  
Energy intake as food is used by the host for metabolic neads and concomitantly by gut bacteria for 
their growth 154. The gut microbiota displays circadian fluctuation 155, mainly driven by diurnal food 
intake, that leads to rhythmic abundance of microbial metabolites 156,157. The systemic oscillation of 
the gut microbiota-derived metabolome reprogrammes the circadian transcriptomes (both locally 
and distally) and thereby regulates host physiology, including metabolic function and drug 
detoxification 157,158. Bacterial adherence to the epithelium shows temporal fluctuations, which also 
correlates to host transcriptional oscillations. Thus, the disruption of gut microbiota oscillatory 
activity, as a result of antibiotic treatment or disordered time of dietary intake, leads to 
disorganization of host rhythmicity 158, suggesting that the gut microbiota serves as a circadian 
regulator of peripheral clocks 159. Altogether, the host–microbe interaction seems to be essential in 
keeping the host clocks timed in an appropriate manner, to integrate the fluctuating environmental 
nutritional signals. According to chronobiomics 160, this interaction is bidirectional and host clock 
influence microbial community configurations. Moreover as the commensal bacteria compete with 
the invading pathogens, the compositional oscillation of the gut microbiota contributes to the 
circadian variation of host defence against invading pathogens. The circadian disruptions induced 
by modern lifestyles might lead to dysbiosis, which could predispose the host to metabolic disorders 
and inflammation  81,161. Regular nutrient infusion into the colon immediately stimulates bacterial 
growth for 20 minutes. Bacterial molecules and metabolites, whose production is regulated by 
bacterial growth phases, control the release of satiety hormones in the intestine. Therefore, systemic 
bacterial molecules could directly switch on central appetite pathways that might incoporate the 
energy status of both the host and its gut microbiota. This modulation of intestinal satiety by short-
term bacterial growth can be coupled with long-term control of appetite, which is regulated by the 
neuropeptidergic circuitry in the hypothalamus 154. 
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[b4] The physiopathology of anti-inflammatory and pro-inflammatory lipids  
Lipids, including high density lipoprotein (HDL) modulate metabolic inflammation and ageing by 
coupling nutrition to microbiota, triglyceride-rich lipoproteins and innate immunity. Phospholipids 
account for 40–60% of total lipids and the surface phospholipids, especially 1-palmitoyl-2-linoleoyl 
phosphatidylcholine (PC), modulate the anti-inflammatory properties of HDL by inhibiting the NF-
kB pathway and inflammation in endothelial cells 162,163. In addition, 1-palmitoyl-2-linoleyl 
phosphatidylcholine is responsible for the ability of HDL to inhibit the activation of T cells that is 
mediated by dendritic cells164. The fatty acid composition of PC influences the anti-inflammatory 
activity of HDL165. Specifically, 1-palmitoyl-2-linoleoyl phosphatidylcholine and 1-palmitoyl-2-
arachidonoyl phosphatidylcholine inhibit VCAM1 expression in activated endothelial cells to a 
greater degree than 1-palmitoyl-2-oleoyl phosphatidylcholine, whereas dipalmitoyl 
phosphatidylcholine does not inhibit it at all. These differences seem to be related to the physical 
properties of phosphatidylcholines, as the increase of unsaturated fatty acid moieties increases their 
fluidity166. Hence, the HDL containing polyunsaturated fatty acid has enhanced anti-inflammatory 
properties, leading to the accelerated efflux of cell-derived pro-inflammatory lipids to more fluid 
particles as an underlying mechanism. HDL also promotes lipopolysaccharide clearance by 
stimulating the interaction of lipopolysaccharide with lipopolysaccharide-binding protein 167,167,168. 
These mechanisms were proposed to underlie the HDL-mediated protection from sepsis. 
Apolipoprotein A1 (ApoA1) is the main apoprotein of HDL and is pivotal in the induction of 
cholesterol efflux from cells. The interaction of HDL or ApoA1 with cells causes cholesterol 
depletion and disturbance of intracellular signalling in specific cholesterol and sphingolipids-
enriched membrane microdomains, named lipid rafts B169,170. Key immunological receptors are 
localized in lipid rafts, including TLR and T cell and B cell receptors171,172. Modification of lipid 
raft composition can modulate raft-dependent immunological signalling because of protein 
delocalization. ApoA1 and HDL substantially decrease lipid raft abundance in monocyte 
membranes because of rapid cholesterol efflux167 and thus directly modulate inflammation. 
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FIGURE LEGENDS 
Figure 1. The seven pillars of ageing. The seven pillars are inflammation, stem cell regeneration, 
macromolecular damage, stress, proteostasis, metabolism and epigenetics 1. The relationship between 
the pillars is shown by the interconnected network. The pillars are shared by ageing and age-related 
diseases.  
Figure 2. The bow tie architecture of the inflammaging machinery. (A) A heterogeneous and broad 
spectrum of exogenous and endogenous danger stimuli (Fan in) interacts with a limited repertoire of 
sensors expressed on the cell surface and in the cytoplasm (Core), and elicits a limited number of 
inflammatory responses (Fan out). Danger molecules can be non-self (pathogen-associated molecular 
patterns, PAMPs), self (damage-associated molecular patterns, DAMPs) and quasi-self (nutritional 
and metabolic products from the gut microbiota) and this multitude of stimuli converges on the same 
evolutionary selected ‘promiscuous’ sensors triggering inflammatory responses. This physiological 
inflammatory process is critical for survival until middle-age. (B) With age the pro-inflammatory 
readout usually increases and becomes detrimental in post-reproductive age. The summation of these 
responses produces a progressive increase of the inflammatory tone that can last several years or 
decades, eventually leading to inflammaging. This process is modulated by a variety of factors, 
including genetics, lifelong lifestyle habits, immunobiography and anatomical variables 61,173. 
Nutrient excess and over-nutrition fits this general scenario, representing a particular type of stimuli 
fueling inflammaging. AHR, aryl hydrocarbon receptor; cGAS, cyclic GMP–AMP synthase; IFN, 
interferon; NF-κB, nuclear factor-κB; NLR, NOD-like receptor. TLR, Toll-like receptor. For 
simplicity, only some of the sensors and inflammatory compounds have been reported.  
Figure 3. The gut microbiota as a key modulator of nutrition and inflammation. The gut microbiota 
transforms environmental signals and dietary molecules into signalling metabolites to communicate 
with different organs and tissues in the host, mediating meal-related inflammation. (A) The 
connection between the gut microbiota and three metabolically important organs (the liver, brain and 
adipose tissue) is shown. The intestine and liver form a bidirectional link, via the portal vein and bile 
duct, called the "gut–liver axis". The gut microbiota also establishes a strong bidirectional connection 
with the central nervous system named the ‘gut–brain axis’. The gut microbiota also communicates 
with the host’s adipose tissue. The crosstalk between the gut microbiota and the other organs is also 
regulated by circadian rhythms, which are driven by a master clock within the suprachiasmatic nuclei 
(SCN) of the hypothalamus and it is mainly entrained by light signals 178. In addition, peripheral 
clocks are located throughout the body, in peripheral organs such as liver, intestine and adipose tissue 
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179. Feeding rhythm and the gut microbiota drive peripheral clock (circadian transcriptional regulation 
across organs) which in turn can contribute to the regulation of the central clock (transcript 
expression). Nutritional and metabolic ‘garbage’ contribute to metaflammation and inflammaging. 
(B) The levels of inflammation during periods of constant undernutrition (low calorie intake), normal 
nutrition (which has periods of feeding and fasting) and overnutrition (high calorie intake) are 
depicted.  
Figure 4. Inflammaging, age trajectories and age-related diseases. (A) Inflammaging is the basis of 
ageing and many age-related chronic diseases, which in turn increase the rate of ageing. Accordingly, 
age-related diseases can be conceptualized as the manifestation of accelerated inflammaging or 
ageing. +++ indicates acceleration or increase. (B) The ageing process and inflammaging show a 
high degree of heterogeneity among individuals. Accordingly, the slopes of the different trajectories 
diverge as a consequence of early critical immunological experiences (including intrauterine stimuli, 
type of birth, neonatal feeding and the use of antibiotics in early childhood) and continue to be 
different depending on events in adulthood (such as geographical place of living, infections, diet and 
vaccinations) 61. The change in the slope of each line suggests that a clinically manifest disease 
accelerates the rate of ageing. Some individuals, such as centenarians and semi-supercentenarians, 
escape or delay the onset of age-related diseases (indicated with the line on the right)  
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Table 1. Biomarkers emerged from the study of ageing and age-related diseases that can be 
translated to metabolic diseases  
Biomarker Molecules involved Effect Reference 
Inflammatory 
cytokines 
TNF   
IL-1 
IL-6 
IL-8 
 
Circulating biomarkers of 
chronic inflammation 
 
51 
N-linked glycans 
profile 
Serum IgG-G0 
digalactosylated or agalactosylated N-linked 
glycan structures 
 
Biological age 
(pathological versus non- 
pathological ageing) 
121 
DNA methylation 
ELOVL2  
353 CpG sites, used to construct the 
epigenetic clock to estimate the methylation 
age  
 
Chronological age and 
biological age 
 
104,106 
Circulating miRNA 
miR-155 
miR-21 
miR-146a 
 
Systemic inflammation  180 
Metabolomics and 
lipidomics 
Glycerophosphoethanolamines 
Glycerophosphocholines 
Glycerolipids 
Gile acids 
Steroids 
Isoprenoids 
Fatty amides 
Sphingolipids 
Tryptophan levels 
L-carnitine esters 
 
Healthy ageing 
(centenarians)   
52,181–183 
Circulating cell-free 
mtDNA 
cf-mtDNA 
 Systemic inflammation 
150 
cf-mtRNA, cell-free mitochondrial DNA; miRNA, microRNA; mtDNA, mitochondrial DNA 
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GLOSSARY 
 
Geroscience: a research field that tries to understand the molecular relationship and link between 
ageing and age-related chronic diseases. The basic assumption is that the machanisms driving 
ageing and those driving age-related diseases largely overlap. A detailed description of the 
strategies are reported in the paper of Kennedy and colleagues 1 
Inflammasome. Inflammasome is a multiprotein intracellular complex that detects pathogenic 
microorganisms and sterile stressors 
Immunosenescence: The term indicate all the most marked changes that occur with aging in the 
adaptive immune system 3. Immunosenescence is responsible for the increased susceptibility of 
elderly to new infectious diseases and is also linked to inflammatory age-related diseases.  
Poikilotherms A cold blooded animals. These animals set biological strategies that allow them to 
elude or endure exposures to environmental temperatures that are below the freezing point of their 
body fluid. Longevity was demonstrated to be increased by temperature reduction in poikilotherms. 
Homeotherms An organism having a body temperature that is constant and largely independent of 
the temperature of its surroundings. Longevity was demonstrated to be increased by temperature 
reduction in homeotherms 
Metabolic endotoxemia: Low-grade, chronic elevation in plasma lipopolisaccaride () 10-50 times 
lower than during septic conditions. It has been observed in obesity studies. It has been suggested 
that metabolic endotoxemia relates to inflammation and may serve a key mediator of metabolic 
derangements observed in obesity  
Metabolomics: metabolomics refers to the systematic identification and quantification of the small 
molecule metabolic products (the metabolome) of a biological system.  
Lipidomics is the study of the structure and function of the complete set of lipids (the lipidome).  
Mitokine: cytokine produced in response to a mitochondrial stress (oxidative stress, unfolded 
proteins, etc.). It can be either nuclear- or mitochondrial-DNA encoded. Other types of stresses can 
induce mitokine production as well, such as endoplasmic reticulum stress. Mitokines include 
FGF21 and GDF15 (nuclear encoded), Humanin and MOTS-c (mitochondrial encoded peptides). 
Mitokines were originally postulated by Dillin and co-workers as soluble elements responsible for 
spreading at systemic level the effects of a local (mitochondrial) stress 184–187. 
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